Filing Details

Accession Number:
0001535610-14-000056
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-04-17 16:17:00
Reporting Period:
2014-04-14
Filing Date:
2014-04-17
Accepted Time:
2014-04-17 16:17:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1541157 Celsus Therapeutics Plc. CLTX Pharmaceutical Preparations (2834) 981034922
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1433766 Hal Mintz C/O Sabby Management, Llc
10 Mountainview Road, Suite 205
Upper Saddle River NJ 07458
No No Yes No
1535610 Sabby Management, Llc 10 Mountainview Road
Suite 205
Upper Saddle River NJ 07458
No No Yes No
1561018 Sabby Healthcare Volatility Master Fund, Ltd. C/O Sabby Management, Llc
10 Mountainview Road, Suite 205
Upper Saddle River NJ 07458
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-04-14 3,000 $5.21 760,930 No 4 P Indirect See Footnotes
Common Stock Acquisiton 2014-04-15 17,100 $5.00 778,030 No 4 P Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
Footnotes
  1. This Form 4 is being filed by Sabby Healthcare Volatility Master Fund, Ltd. ("SHVMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. The Advisor is the investment manager of SHVMF. Mr. Mintz is the manager of the Advisor.
  2. The amounts reported herein reflect the entire amount of the Issuer's securities held by SHVMF as of each transaction date. Each of the Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed an admission that either the Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise.